Cadila Pharmaceuticals Ltd, a care-focused, research-driven company has supported the ‘Health Mela’ organized by the district administration of Unjha, Mehasna in North Gujarat through its CSR arm Indrashil Kaka-Ba and Kala-Budh Public Charitable Trust.
The ‘Health Mela,’ organised with the aim to sensitize people about preventive healthcare and provided basic treatment to patients at no cost, was supported by the Health Department of the Government of Gujarat. Cadila Pharmaceuticals supplied medicines to the “Health Mela” to support the government initiative to provide quality medicine to the needy and also be an active partner in preventive healthcare.
State minister for Health & Family Welfare, Government of Gujarat, Shri Rushikesh Patel acknowledged the role of Cadila Pharmaceuticals and felicitated the certificate of appreciation to support in reaching out the benefits of health mela to more than 5000 people.
Indrashil Kaka-Ba and Kala-Budh Public Charitable Trust, a CSR initiative of Cadila Pharmaceutical, is continuously serving and supporting social causes like education of kids in rural areas, building infrastructure like libraries, school renovation, tree plantation of more than 1 lakhs trees and organizing periodic health camps in rural areas which benefits the marginalized section of the society.
“In sync with our founder Shri Indravadan A Modi’s vision and promise, Cadila Pharmaceuticals is committed to contributing to society in every way and will continue to make all efforts to give back as a part of our Corporate Social Responsibility. By supporting the Health Mela, the Cadila team reassures the commitment of its founder to be part of solutions to the overall health concerns of the rural poor. We thank the Government of Gujarat for their appreciation of our commitment,” stated Dr Bharat Champaneria, Trustee at Indrashil Kaka-Ba and Kala Budh Public Charitable Trust, the charitable arm of Cadila Pharmaceuticals.
Disclaimer: This media release is auto-generated. The CSR Journal is not responsible for the content.
